Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its embattled chief executive face a long war against an activist that hates to ...

Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.

Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...

Will this clash between a major shareholder and management, current and former, harm the stock? Or is the situation merely an ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

Companies like Amazon have required a return to the office five days a week despite findings showing benefits to employers ...

Here are some of the major companies whose stocks moved on the week’s news.

Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge took an ...

Activist investor Starboard Value accused Pfizer of pressuring its former CEO Ian Read and ex-CFO Frank D’Amelio to halt ...